Advertisement

The journal of nutrition, health & aging

, Volume 21, Issue 5, pp 480–486 | Cite as

Tea consumption and health-related quality of life in older adults

  • C.-W. Pan
  • Q. Ma
  • H.-P. Sun
  • Y. Xu
  • N. Luo
  • Pei WangEmail author
Article

Abstract

Background

Although tea consumption has been reported to have various health benefits in humans, its association with health-related quality of life (HRQOL) has not been investigated directly. We aimed to examine the relationship between tea consumption and HRQOL among older Chinese adults.

Methods

We analyzed community-based cross-sectional data of 5,557 older Chinese individuals aged 60 years or older who participated in the Weitang Geriatric Diseases study. Information on tea consumption and HRQOL assessed by the European Quality of Life-5 dimensions (EQ-5D) were collected by questionnaires. We estimated the relationship of tea consumption and the EQ-5D index score using linear regression models and the association between tea consumption and self-reported EQ-5D health problems using logistic regression models.

Results

The EQ-5D index score was higher for habitual tea drinkers than their counterparts. In multivariate linear analyses controlling for socio-demographic conditions, health conditions, and lifestyle habits, the differences in ED-5D index score between individuals with and without tea drinking habits was 0.012 (95% confidence interval, 0.006-0.017). In multivariate logistic analyses, habitual tea drinking was inversely associated with reporting of problems in EQ-5D dimensions mobility (odds ration [OR], 0.44; 95% CI: 0.23-0.84); pain/discomfort (OR, 0.74; 95% CI: 0.61-0.90); and anxiety/depression (OR, 0.60; 95% CI: 0.38-0.97). These associations were more evident for black or oolong tea than green tea.

Conclusion

Habitual tea consumption was associated with better HRQOL in older adults.

Key words

Tea consumption health-related quality of life EQ-5D older adults 

References

  1. 1.
    Statista. Global production and exports of tea 2004-2012. http://www.statista.com/statistics/264183/global-production-and-exports-of-tea-since-2004/. Accessed 14, May, 2015.Google Scholar
  2. 2.
    Xu N, Chen ZM. Green tea, black tea, and semi-fermented tea. In: Zhen Y-S, ed. Tea bioactivity and therapeutic potential. London, United Kingdom: CRC Press UK, 2002:35–54.Google Scholar
  3. 3.
    Chen ZM, Xu N. Agronomy and commercial production of tea. In: Zhen Y-S, ed. Tea: bioactivity and therapeutic potential. London, United Kingdom: CRC Press UK, 2002:243–256.Google Scholar
  4. 4.
    Cabrera C, Gimenez R, Lopez MC. Determination of tea components with antioxidant activity. J Agric Food Chem. 2003;51(5):4427–4435.CrossRefPubMedGoogle Scholar
  5. 5.
    Osada K, Takahashi M, Hoshina S, et al. Tea catechins inhibit cholesterol oxidation accompanying oxidation of low density lipoprotein in vitro. Comp Biochem Physiol Part C Toxicol Pharmacol. 2001;128(2):153–164.CrossRefGoogle Scholar
  6. 6.
    Tipoe GL, Leung TM, Hung MW, et al. Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovasc Hematol Disord Drug Targets. 2007;7(2):135–144.CrossRefPubMedGoogle Scholar
  7. 7.
    Reznichenko L, Amit T, Youdim MB, et al. Green tea polyphenol (-)-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neuroprotective outgrowth. J Neurochem. 2005;93(5):1157–1167.CrossRefPubMedGoogle Scholar
  8. 8.
    Nathan PJ, Lu K, Gray M, et al. The neuropharmacology of L-theanine (N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent. J Herb Pharmacother. 2006;6(2):21–30.PubMedGoogle Scholar
  9. 9.
    Wang W, Yang Y, Zhang W, et al. Association of tea consumption and the risk of oral cancer: a meta-analysis. Oral Oncology. 2014;50(4):276–281.CrossRefPubMedGoogle Scholar
  10. 10.
    Sun CL, Yuan JM, Koh WP, et al. Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis. 2006;27(7):1301–1309.CrossRefPubMedGoogle Scholar
  11. 11.
    Sun CL, Yuan JM, Koh WP, et al. Green tea, black tea and breast cancer risk: a metaanalysis of epidemiologic studies. Carcinogenesis. 2006;27(7):1310–1315.CrossRefPubMedGoogle Scholar
  12. 12.
    Lambert JD. Does tea prevent cancer? Evidence from laboratory and human intervention studies. Am J Clin Nutr. 2013;98(6):1667S–1675S.CrossRefPubMedGoogle Scholar
  13. 13.
    Huxley RR, Neil HA. The relationship between dietary flavonol intake and coronary heart disease mortality: a meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2003;57(8):904–908.CrossRefPubMedGoogle Scholar
  14. 14.
    Arab L, Khan F, Lam H. Tea consumption and cardiovascular disease risk. Am J Clin Nutr. 2013;98(6):1651S–1659S.CrossRefPubMedGoogle Scholar
  15. 15.
    Nabavi S, Daglia M, Moghaddam A, et al. Tea consumption and risk of ischemic stroke: a brief review of the literature. Curr pharm Biotechnol. 2014;15(4):298–303.CrossRefPubMedGoogle Scholar
  16. 16.
    Arab L, Liu W, Elashoff D. Green and black tea consumption and risk of stroke: a meta-analysis. Stroke. 2009;40(5):1786–1792.CrossRefPubMedGoogle Scholar
  17. 17.
    Odegaard AO, Pereira MA, Koh WP, et al. Coffee, tea, and incident type 2 diabetes: the Singapore Chinese Health Study. Am J Clin Nutr. 2008;88(4):979–985.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Katiya SK, Raman C. Green tea: a new option for the prevention of control of osteoarthritis. Arthritis Res Ther. 2011;13(4):121.CrossRefGoogle Scholar
  19. 19.
    Feng L, Chong MS, Lim WS, et al. Tea for Alzheimer prevention. J Prev Alz Dis. 2015;2(2):136–141.Google Scholar
  20. 20.
    Kuriyama S, Shimazu T, Ohmori K, et al. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 2006;296(10):1255–1265.CrossRefPubMedGoogle Scholar
  21. 21.
    Kuriyama S, Hozawa A, Ohmori K, et al. Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. Am J Clin Nutr. 2006;83(2):355–361.PubMedGoogle Scholar
  22. 22.
    Ng TP, Feng L, Niti M, et al. Tea consumption and cognitive impairment and decline in older Chinese adults. Am J Clin Nutr. 2008;88(1):224–231.PubMedGoogle Scholar
  23. 23.
    Panza F, Solfrizzi V, Barulli MR, et al. Coffee, tea, and caffeine consumption and prevention of later-life cognitive decline and dementia: a systematic review. J Nutr Health Aging. 2015;19(3):313–328.CrossRefPubMedGoogle Scholar
  24. 24.
    Hintikka J, Tolmunen T, Honkalampi K, et al. Daily tea drinking is associated with a low level of depressive symptoms in the Finnish general population. Eur J Epidemiol. 2005;20(4):359–363.CrossRefPubMedGoogle Scholar
  25. 25.
    Niu K, Hozawa A, Kuriyama S, et al. Green tea consumption is associated with depressive symptoms in the elderly. Am J Clin Nutr. 2009;90(6):1615–1622.CrossRefPubMedGoogle Scholar
  26. 26.
    Hozawa A, Kuryiyama S, Nakaya N, et al. Green tea consumption is associated with lower psychological distress in a general population: the Ohsaki Chort 2006 study. Am J Clin Nutr. 2009;90(5):1390–1396.CrossRefPubMedGoogle Scholar
  27. 27.
    NG TP, Aung KCY, Feng L, et al. Tea consumption and physical function in older adults: a cross-sectional study. J Nutr Health Aging. 2014;18(2):161–166.CrossRefPubMedGoogle Scholar
  28. 28.
    Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):1303–1307.CrossRefGoogle Scholar
  29. 29.
    Gusi N, Olivares, Rajendram. The EQ-5D health-realted quality of life questionnaire. In: Preedy VR, Watson RR, eds. Handbook of disease brudents and quality of life measures. New York, United States: Sprigner-Verlag New York. 2010:87–99.CrossRefGoogle Scholar
  30. 30.
    Liu G, Wu H, Li M, et al. Chinese time trade-off values for EQ-5D health states. Value Health. 2014;17(5):597–603.CrossRefPubMedGoogle Scholar
  31. 31.
    Wang H, Kindig DA, Mullahy J. Variation in Chinese population health related quality of life: results from a EuroQol study in Beijing, China. Qual Life Res. 2005;14(1):119–132.CrossRefPubMedGoogle Scholar
  32. 32.
    Zhao FL, Yue M, Yang H, et al. Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients. Value Health, 2010;13(5):649–656.CrossRefPubMedGoogle Scholar
  33. 33.
    Wang HM, Patrick DL, Edwards TC, et al. Validation of the EQ-5D in a general population sample in urban China. Qual Life Res. 2012;21(1):155–160.CrossRefPubMedGoogle Scholar
  34. 34.
    Wu J, Han Y, Zhao FL, et al. Validation and comparison of EuroQol-5 dimension (EQ-5D) and short form-6 (SF-6D) among stable angina patients. Health Qual Life Outcomes. 2014;12:156.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Sahadevan S, Tan JL, Tan T, et al. Cognitive testing of elderly Chinese people in Singapore: Influence of education and age on normative scores. Age and Ageing. 1997;26(6):481–486.CrossRefPubMedGoogle Scholar
  36. 36.
    Chylack LT, Jr., Wolfe JK, Singer DM, et al. The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group. Arch Ophthalmol. 1993;111(6):831–836.CrossRefPubMedGoogle Scholar
  37. 37.
    Totsch SK, Waite ME, Sorge RE. Dietary influence on pain via immune system. Prog Mol Biol Transl Sci. 2015;13:435–469.CrossRefGoogle Scholar
  38. 38.
    Tomata Y, Kakizaki M, Nakaya N, et al. Green tea consumption and the risk of incident functional disability in elderly Japanese: the Ohsaki Cohort 2006 study. Am J Clin Nutr. 2012;95(3):732–739.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Serafini M, Ghiselli A, Ferro-Luzzi A. In vivo antioxidant effect of green tea and black tea in man. Eur J Clin Nutr. 1996;50(1):28–32.PubMedGoogle Scholar
  40. 40.
    Weinreb O, Mandel S, Amit T, et al. Neurological mechanisms of green tea polyphenols in Alzheimer’s and Parkinson’s disease. J Nutr Biochem. 2004;15(9):506–516.CrossRefPubMedGoogle Scholar
  41. 41.
    Cao H, Kelly MA, Kari F, et al. Green tea increases anti-inflammatory tristetraprolin and decrease pro-inflammatory tumor necrosis factor mRNA in rats. J Inflamm(Lond). 2007;4:1.CrossRefPubMedCentralGoogle Scholar
  42. 42.
    Cesari M, Pahor M, Bartali B, et al. Antioxidants and physical performance in elderly persons: the Invecchiare in Chianti (InCHIANTI) study. Am J Clin Nutr. 2004;79(2):289–294.PubMedGoogle Scholar
  43. 43.
    Pan T, Jankovic J, Le W. Potential therapeutic properties of green tea polyphenols in Parkinson’s disease. Drugs Aging. 2003;20(10):711–721.CrossRefPubMedGoogle Scholar
  44. 44.
    Kimujra K, Ozeki M, Juneja LR,et al. L-Theanine reduces psychological and physiological stress responses. Biol Psychol. 2007;74(1):39–45.CrossRefGoogle Scholar
  45. 45.
    Nathan PJ, Lu K, Gray M, et al. The neuropharmacology of L-theanine (N-ethyl-L-glutamine): a possible neuroprotective and cognitive enhancing agent. J Herb Pharmacother. 2006;6(2):21–30.PubMedGoogle Scholar
  46. 46.
    Henning SM, Niu Y, Lee NH, et al. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am J Clin Nutr. 2004;80(6):1558–1564.PubMedGoogle Scholar
  47. 47.
    Luczaj W, Skrzydlewska E. Antioxidative properties of black tea. Prev Med. 2005;40(6):910–918.CrossRefPubMedGoogle Scholar
  48. 48.
    Walters SJ, Brazier JE. Comparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6D. Qual Life Res. 2005;14(6):1523–1532.CrossRefPubMedGoogle Scholar
  49. 49.
    Tea Association of the U.S.A.Inc. Tea fact sheet-2014. http://www.teausa.com/14655/tea-fact-sheet. Accessed 14, December, 2015.Google Scholar
  50. 50.
    Drinking four or more cups of tea can lower the risk of middle-aged related diabetes. Daily Mail Online. http://www.dailymail.co.uk/health/article-2154409/Drinking-tealower-risk-diabetes—drink-cups-day.html. Accessed 4, April, 2016.Google Scholar
  51. 51.
    Ageing and Life Course. World Health Organization. http://www.who.int/ageing/en/. Accessed 14, May, 2015.Google Scholar
  52. 30.
    Ehrnborg C, Lange KH, Dall R, Christiansen JS, Lundberg PA, Baxter RC, Boroujerdi MA, Bengtsson BA, Healey ML, Pentecost C, Longobardi S, Napoli R, Rosén T; GH-2000 Study Group. The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. J Clin Endocrinol Metab. 2003;88(1):394–401.CrossRefPubMedGoogle Scholar

Copyright information

© Serdi and Springer-Verlag France 2017

Authors and Affiliations

  • C.-W. Pan
    • 1
  • Q. Ma
    • 2
  • H.-P. Sun
    • 1
  • Y. Xu
    • 1
  • N. Luo
    • 3
  • Pei Wang
    • 3
    • 4
    Email author
  1. 1.Jiangsu Key Laboratory of Preventive and Translational Medicine for Geriatric Diseases, School of Public HealthMedical College of Soochow UniversitySuzhouChina
  2. 2.The 3rd People’s Hospital of Xiangcheng DistrictSuzhouChina
  3. 3.Saw Swee Hock School of Public HealthNational University of SingaporeSingaporeSingapore
  4. 4.School of Public HealthFudan UniversityShanghaiChina

Personalised recommendations